This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Novo Nordisk Healthcare Ag. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Yuwen Xu - Innovator in Pharmaceutical Compositions
Introduction
Yuwen Xu is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions that activate pyruvate kinase R (PKR). His work is essential in advancing therapeutic options for various medical conditions.
Latest Patents
Yuwen Xu holds 1 patent for his invention titled "Pyruvate kinase R (PKR) activating compositions." This patent includes crystalline solid forms, spray-dried dispersions, and pharmaceutical compositions, such as solid oral dosage forms of a specific compound. The compound, referred to as 'Compound 1,' is characterized by its unique chemical structure and preparation methods.
Career Highlights
Yuwen Xu is currently associated with Novo Nordisk Healthcare AG, a leading company in the healthcare sector. His role involves research and development aimed at creating effective pharmaceutical solutions. His expertise in the field has positioned him as a valuable asset to his organization.
Collaborations
Yuwen Xu collaborates with talented professionals, including Sonia Rodriguez Rodriguez and Shanming Kuang. These collaborations enhance the innovative capacity of their projects and contribute to the advancement of their research initiatives.
Conclusion
Yuwen Xu's contributions to pharmaceutical compositions demonstrate his commitment to innovation in healthcare. His work continues to impact the industry positively, paving the way for new therapeutic advancements.